GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

ECGI Holdings ECGI · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.01

+6.38%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$3,579

FY2015FY2025

Net income

−$2.4m

FY2015FY2025

Free cash flow

−$84,392

FY2015FY2025

Shareholders' equity

−$4.9m

FY2015FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2015
Revenue$3,579$2,673————————
Gross profit−$217,449————————−$1,328
Research and development—————————$1.2m
Operating income−$515,213−$473,000−$407,000−$1.5m−$1.1m−$27,385−$12,750−$55,110—−$2.4m
Net income−$2.4m$1.0m−$3.6m−$1.1m−$4.4m−$49,834−$45,088−$61,543$15,421−$2.5m
Diluted earnings per share-0.000.01-0.04-0.05-0.22-2.90-0.00-0.000.00-0.44

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2015
Total assets$4.8m$5.1m$5.2m$4.6m$4.5m$2,866$6,751—$4,387$1.3m
Cash and short-term investments$2,778—$13$15,016$4,189$1,116$2,251—$2,387$32,427
Total liabilities$9.7m$11.1m$11.9m$8.4m$8.8m$360,607$314,658—$475,383$1.7m
Debt$2.8m$3.0m$3.2m$1.7m$1.2m$245,000$240,000—$427,959$1.1m
Shareholders' equity−$4.9m−$6.0m−$6.7m−$3.9m−$4.3m−$357,741−$307,907—−$470,996−$478,508
Shares outstanding510m166m99m22m20m0m17m809m809m6m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2015
Cash from operations−$84,392−$410,895−$259,054−$211,173−$237,297−$6,135−$12,749−$55,112—−$1.0m
Capital spending—−$5−$5−$3−$4————−$150,000
Free cash flow−$84,392−$410,900−$259,059−$211,176−$237,301−$6,135−$12,749−$55,112—−$1.2m

Latest quarters

By quarter end

May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024
Revenue$119,040$62,480——$916$685$1,978—
Gross profit$63,782$7,222−$55,257−$55,257−$72,760—−$53,279—
Operating income−$5,610−$31,637−$97,095−$109,067−$278,864−$66,270−$61,012−$172,709
Net income−$5.3m$1.1m−$1.2m−$222,723−$1.9m$194,225−$422,092−$182,045
Diluted earnings per share-0.010.00-0.00-0.00-0.000.00-0.00-0.00
Total assets$5.0m$4.9m$5.0m$4.8m$4.8m$5.1m$5.1m$5.1m
Cash and short-term investments—$402$3,323$2,778$10,017———
Debt$3.8m$2.1m$1.9m$2.0m$2.0m$2.0m$2.3m$2.2m
Shareholders' equity−$10.2m−$4.9m−$6.0m−$4.9m−$4.7m−$2.9m−$6.0m−$6.0m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-29.3%79.8%31.6%
Net income29.3%116.4%52.7%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-15806.3%———
Net margin-21254.1%———

Valuation history

At each fiscal year end

FY2025FY2024
Price to earnings-0.10.1
Price to sales33.322.8

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-50%401%133%4806%16571%4587%2469%118587%21711%59%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 20-to-1 reverse split · 15 Aug 2019

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.